Govt sets target to increase Jan Aushadhi Kendras to 25000 by March 2027

Written By :  Ruchika Sharma
Published On 2025-12-21 09:00 GMT   |   Update On 2025-12-21 09:00 GMT
Advertisement

New Delhi: With a view to augment the reach of Janaushadhi scheme to the citizens, Government has set a target of increasing the number of JAKs opened across the country to 25,000 by March 2027, the Minister informed Parliament.

In a written reply in Rajya Sabha, the Union Minister of State in the Ministry of Chemicals and Fertilizers, Smt. Anupriya Patel said that 17,610 Jan Aushadhi Kendras (JAKs) have been opened across the country under the scheme as of November 30, 2025, as against only 80 in the year 2014.

Advertisement

Awareness about availability of quality affordable medicines under the scheme and confidence in Janaushadhi products has grown steadily, as reflected in rising sale volumes as well as a growing basket of Janaushadhi products. This has increased the viability of JAKs and enhanced the attractiveness of opening JAKs to entrepreneurs. As a result, the pace of opening of JAKs has gained momentum in recent years, as reflected in 37% increase in the number of JAKs and 38% increase in the maximum retail price value of sales under the scheme during the last financial year.

JAKs are opened by inviting applications from individual entrepreneurs, non-governmental organisations, societies, trusts, firms, private companies, etc., for which applications have been invited online across the country, including the State of Andhra Pradesh, through the scheme’s website.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News